(SHL) Siemens Healthineers - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000SHL1006
SHL: Imaging, Diagnostics, Oncology, Surgery, Therapy
Siemens Healthineers AG (XETRA:SHL) is a leading global medical technology company focused on enabling healthcare providers to deliver high-quality patient care. The company operates through four core segments: Imaging, Diagnostics, Varian, and Advanced Therapies. Its Imaging segment offers a comprehensive portfolio of diagnostic imaging systems, including magnetic resonance imaging (MRI), computed tomography (CT), X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic solutions, including laboratory and point-of-care testing, as well as workflow management and informatics solutions. The Varian segment specializes in cancer care, offering radiation oncology systems, treatment planning software, and digital solutions for oncology workflows. The Advanced Therapies segment focuses on image-guided minimally invasive therapies, including angiography systems and mobile C-arms for cardiology, radiology, and surgery.
Siemens Healthineers AG also provides a wide range of customer services, including equipment maintenance, repair, and performance management. The company offers training, clinical education, and e-learning programs to healthcare professionals. Additionally, it provides planning, design, and financing services for healthcare facilities, as well as asset management and managed departmental services for laboratories. Its digital healthcare consulting services aim to optimize healthcare workflows and improve patient outcomes. The company was spun off from Siemens AG in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft and is a key player in the global healthcare technology industry.
Over the next three months, Siemens Healthineers AG (XETRA:SHL) is expected to experience a period of consolidation based on its current technical and fundamental profile. The stock has shown a recent downtrend, with its SMA 20 (47.19) and SMA 50 (51.33) above the current price of 44.66, indicating potential resistance levels. The ATR of 1.47 suggests moderate volatility, which could lead to price fluctuations within a narrow range. The SMA 200 (50.96) is also above the current price, reinforcing the bearish sentiment in the short term.
Fundamentally, the companys P/E ratio of 25.23 indicates a premium valuation compared to its forward P/E of 16.78, suggesting expectations of future earnings growth. The P/B ratio of 2.53 reflects a strong balance sheet, while the P/S ratio of 2.21 indicates reasonable revenue multiples. With a market cap of 49986.60M EUR and an RoE of 10.04%, Siemens Healthineers AG is well-positioned for long-term growth, but near-term price movements may be influenced by broader market conditions and investor sentiment.
Additional Sources for SHL Stock
SHL Stock Overview
| Market Cap in USD | 56,735m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Equipment |
| IPO / Inception |
SHL Stock Ratings
| Growth Rating | 19.3 |
| Fundamental | 54.4 |
| Dividend Rating | 52.8 |
| Rel. Strength | -9.16 |
| Analysts | - |
| Fair Price Momentum | 40.50 EUR |
| Fair Price DCF | 35.26 EUR |
SHL Dividends
| Dividend Yield 12m | 1.93% |
| Yield on Cost 5y | 2.52% |
| Annual Growth 5y | 3.50% |
| Payout Consistency | 98.6% |
SHL Growth Ratios
| Growth Correlation 3m | -86.8% |
| Growth Correlation 12m | -14.9% |
| Growth Correlation 5y | 47.5% |
| CAGR 5y | 4.39% |
| CAGR/Max DD 5y | 0.12 |
| Sharpe Ratio 12m | -0.18 |
| Alpha | -18.55 |
| Beta | 0.880 |
| Volatility | 33.72% |
| Current Volume | 704.4k |
| Average Volume 20d | 1051.6k |
As of April 26, 2025, the stock is trading at EUR 46.84 with a total of 704,376 shares traded.
Over the past week, the price has changed by +4.60%, over one month by -9.82%, over three months by -11.43% and over the past year by -8.93%.
Partly, yes. Based on ValueRay Fundamental Analyses, Siemens Healthineers (XETRA:SHL) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.39 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SHL as of April 2025 is 40.50. This means that SHL is currently overvalued and has a potential downside of -13.54%.
Siemens Healthineers has no consensus analysts rating.
According to ValueRays Forecast Model, SHL Siemens Healthineers will be worth about 45.2 in April 2026. The stock is currently trading at 46.84. This means that the stock has a potential downside of -3.5%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 62.3 | 33% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 45.2 | -3.5% |